Search

Search Constraints

You searched for: Author/Creator Shaffer, Brian

Search Results

1. 595. Letermovir (LTV) for Secondary Cytomegalovirus (CMV) Prevention in High Risk Hematopoietic Cell Transplant (HCT) Recipients: Interim Results of a Single Center, Open Label Study. (4th December 2021)

2. 595. Letermovir (LTV) for Secondary Cytomegalovirus (CMV) Prevention in High Risk Hematopoietic Cell Transplant (HCT) Recipients: Interim Results of a Single Center, Open Label Study. (4th December 2021)

3. Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34+‐selected allogeneic transplantation. Issue 1 (10th October 2020)

4. Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. (24th May 2021)

5. Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study . (3rd January 2022)

6. Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation. Issue 7 (7th June 2022)